Occupational risk factors for relapse-free survival in bladder cancer patients

References

• Boffetta, P., and Silverman, D. T. 2001. A meta-analysis of bladder cancer and diesel exhaust exposure. Epidemiology 12: 125–30.
   PubMed Web of Science ®Google Scholar
• Colt, J. S., Karagas, M. R., Schwenn, M., Baris, D., Johnson, A., Stewart, P., Verrill, C., Moore, L. E., Lubin, J., Ward, M. H., Samanic, C., Rothman, N., Cantor, K. P., Beane Freeman, L. E., Schned, A., Cherala, S., and Silverman, D. T. 2011. Occupation and bladder cancer in a population-based case-control study in northern New England. Occup. Environ. Med. 68: 239–49.
   PubMed Web of Science ®Google Scholar
• Crivelli, J. J., Xylinas, E., Kluth, L. A., Rieken, M., Rink, M., and Shariat, S. F. 2014. Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature. Eur. Urol. 65: 742–54.
   PubMed Web of Science ®Google Scholar
• Figueroa, J. D., Han, S. S., Garcia-Closas, M., Baris, D., Jacobs, E. J., Kogevinas, M., Schwenn, M., Malats, N., Johnson, A., Purdue, M. P., Caporaso, N., Landi, M. T., Prokunina-Olsson, L., Wang, Z., Hutchinson, A., Burdette, L., Wheeler, W., Vineis, P., Siddiq, A., Cortessis, V. K., Kooperberg, C., Cussenot, O., Benhamou, S., Prescott, J., Porru, S., Bueno-de-Mesquita, H. B., Trichopoulos, D., Ljungberg, B., Clavel-Chapelon, F., Weiderpass, E., Krogh, V., Dorronsoro, M., Travis, R., Tjønneland, A., Brennan, P., Chang-Claude, J., Riboli, E., Conti, D., Gago-Dominguez, M., Stern, M. C., Pike, M. C., Van Den Berg, D., Yuan, J. M., Hohensee, C., Rodabough, R., Cancel-Tassin, G., Roupret, M., Comperat, E., Chen, C., De Vivo, I., Giovannucci, E., Hunter, D. J., Kraft, P., Lindstrom, S., Carta, A., Pavanello, S., Arici, C., Mastrangelo, G., Karagas, M. R., Schned, A., Armenti, K. R., Hosain, G. M., Haiman, C. A., Fraumeni, J. F., Jr., Chanock, S.J., Chatterjee, N., Rothman, N., and Silverman, D. T. 2014. Genome-wide interaction study of smoking and bladder cancer risk. Carcinogenesis 35:1737–44.
   PubMed Web of Science ®Google Scholar
• Figueroa, J. D., Koutros, S., Colt, J. S., Kogevinas, M., Garcia-Closas, M., Real, F. X., Friesen, M. C., Baris, D., Stewart, P., Schwenn, M., Johnson, A., Karagas, M. R., Armenti, K. R., Moore, L. E., Schned, A., Lenz, P., Prokunina-Olsson, L., Banday, A. R., Paquin, A., Ylaya, K., Chung, J. Y., Hewitt, S. M., Nickerson, M. L., Tardón, A., Serra, C., Carrato, A., García-Closas, R., Lloreta, J., Malats, N., Fraumeni, J. F. Jr., Chanock, S. J., Chatterjee, N., Rothman, N., and Silverman, D. T. 2015. Modification of occupational exposures on bladder cancer risk by common genetic polymorphisms. J. Natl. Cancer Inst. 107:djv223. doi:10.1093/jnci/djv223.
   Google Scholar
• Gaertner, R. R. W., and Theriault, G. P. 2002. Risk of bladder cancer in foundry workers: A meta-analysis. Occup. Environ. Med. 59: 655–63.
   PubMed Web of Science ®Google Scholar
• Garcia-Closas, M., Rothman, N., Figueroa, J. D., Prokunina-Olsson, L., Han, S. S., Baris, D., Jacobs, E. J., Malats, N., De Vivo, I., Albanes, D., Purdue, M. P., Sharma, S., Fu, Y. P., Kogevinas, M., Wang, Z., Tang, W., Tardón, A., Serra, C., Carrato, A., García-Closas, R., Lloreta, J., Johnson, A., Schwenn, M., Karagas, M. R., Schned, A., Andriole, G. Jr., Grubb, R. 3rd, Black, A., Gapstur, S. M., Thun, M., Diver, W. R., Weinstein, S. J., Virtamo, J., Hunter, D. J., Caporaso, N., Landi, M. T., Hutchinson, A., Burdett, L., Jacobs, K. B., Yeager, M., Fraumeni, J. F., Jr., Chanock, S. J., Silverman, D. T., and Chatterjee, N. 2013. Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Cancer Res. 73: 2211–20.
   PubMed Web of Science ®Google Scholar
• Geller, F., Urfer, W., and Golka, K. 2008. Bladder cancer and occupational exposures in North Rhine-Westphalia, Germany. J. Toxicol. Environ. Health A 71: 856–58.
   PubMed Web of Science ®Google Scholar
• Golka, K., Bandel, T., Schlaefke, S., Reich, S. E., Reckwitz, T., Urfer, W., Bremicker, K. D., Neugebauer, W., Soekeland, J., and Bolt, H. M. 1998. Urothelial cancer of the bladder in an area of former coal, iron, and steel industries in Germany: A case-control study. Int. J. Occup. Environ. Health 4: 79–84.
   PubMedGoogle Scholar
• Golka, K., Heitmann, P., Gieseler, F., Hodzic, J., Masche, N., Bolt, H. M., and Geller, F. 2008. Elevated bladder cancer risk due to colorants–a statewide case-control study in North Rhine-Westphalia, Germany. J. Toxicol. Environ. Health A 71: 851–55.
   PubMed Web of Science ®Google Scholar
• Golka, K., Hermes, M., Selinski, S., Blaszkewicz, M., Bolt, H. M., Roth, G., Dietrich, H., Prager, H.-M., Ickstadt, K., and Hengstler, J. G. 2009. Susceptibility to urinary bladder cancer: relevance of rs9642880T, GSTM1 0/0 and occupational exposure. Pharmacogenet. Genomics 19: 903–6.
   PubMed Web of Science ®Google Scholar
• Golka, K., Kopps, S., and Myslak, Z. W. 2004a. Carcinogenicity of azo colorants: influence of solubility and bioavailability. Toxicol. Lett. 151: 203–10.
   PubMed Web of Science ®Google Scholar
• Golka, K., Kopps, S., Prager, H.-M., Mende, S. v., Thiel, R., Jungmann, O., Zumbe, J., Bolt, H. M., Blaszkewicz, M., Hengstler, J. G., and Selinski, S. 2012. Bladder cancer in crack testers applying azo dye-based sprays to metal bodies. J. Toxicol. Environ. Health A 75: 566–71.
   PubMed Web of Science ®Google Scholar
• Golka, K., Prior, V., Blaszkewicz, M., and Bolt, H. M. 2002. The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: A review considering ethnic differences. Toxicol. Lett. 128: 229–41.
   PubMed Web of Science ®Google Scholar
• Golka, K., and Weistenhöfer, W. 2008. Fire fighters, combustion products, and urothelial cancer. J. Toxicol. Environ. Health B 11: 32–44.
   PubMed Web of Science ®Google Scholar
• Golka, K., Wiese, A., Assennato, G., and Bolt, H. M. 2004b. Occupational exposure and urological cancer. World J. Urol. 21: 382–91.
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer. 1981. Evaluation of the carcinogenic risk of chemicals to humans: Wood, leather and some associated industries. Geneva, Switzerland: World Health Organization.
   Google Scholar
• Jenkins, W. D., Christian, W. J., Mueller, G., and Robbins, K. T. 2013. Population cancer risks associated with coal mining: a systematic review. PloS ONE 8: e71312.
   PubMed Web of Science ®Google Scholar
• Knecht, U., and Woitowitz, H. J. 1989. Risk of cancer from the use of tar bitumen in road works. Br. J. Ind. Med. 46: 24–30.
   PubMedGoogle Scholar
• Knecht, U., and Woitowitz, H. J. 1990. Krebsgefährdung bei Verwendung von Pechbitumen im Strassenbau (PT-AT). 1. Auflage. Bonn, Germany: Wirtschaftsverlag NW Verlag für neue Wissenschaft GmbH.
   Google Scholar
• Kvam, B. M., Romundstad, P. R., Boffetta, P., and Andersen, A. 2005. Cancer in the Norwegian printing industry. Scand. J. Work Environ. Health 31: 36–43.
   PubMed Web of Science ®Google Scholar
• Moore, L. E., Baris, D. R., Figueroa, J. D., Garcia-Closas, M., Karagas, M. R., Schwenn, M. R., Johnson, A. T., Lubin, J. H., Hein, D. W., Dagnall, C. L., Colt, J. S., Kida, M., Jones, M. A., Schned, A. R., Cherala, S. S., Chanock, S. J., Cantor, K. P., Silverman, D. T., and Rothman, N. 2011. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: Results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis 32:182–89.
   PubMed Web of Science ®Google Scholar
• Ovsiannikov, D., Selinski, S., Lehmann, M.-L., Blaszkewicz, M., Moormann, O., Haenel, M. W., Hengstler, J. G., and Golka, K. 2012. Polymorphic enzymes, urinary bladder cancer risk, and structural change in the local industry. J. Toxicol. Environ. Health A 75: 557–65.
   PubMed Web of Science ®Google Scholar
• Reulen, R. C., Kellen, E., Buntinx, F., Brinkman, M., and Zeegers, M. P. 2008. A meta-analysis on the association between bladder cancer and occupation. Scand. J. Urol. Nephrol. Suppl. 218: 64–78.
   PubMedGoogle Scholar
• Rink, M., Furberg, H., Zabor, E. C., Xylinas, E., Babjuk, M., Pycha, A., Lotan, Y., Karakiewicz, P. I., Novara, G., Robinson, B. D., Montorsi, F., Chun, F. K., Scherr, D. S., and Shariat, S. F. 2013. Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer. Eur. Urol. 63: 724–32.
   PubMed Web of Science ®Google Scholar
• Rota, M., Bosetti, C., Boccia, S., Boffetta, P., and La Vecchia, C. 2014. Occupational exposures to polycyclic aromatic hydrocarbons and respiratory and urinary tract cancers: An updated systematic review and a meta-analysis to 2014. Arch. Toxicol. 88: 1479–90.
   PubMed Web of Science ®Google Scholar
• Roth, E., Selinski, S., Schikowsky, C., Seidel, T., Volkert, F., Blaszkewicz, M., Hengstler, J. G., and Golka, K. 2012. Bladder cancer survival in a former industrial area in Saxony-Anhalt, Germany. J. Toxicol. Environ. Health A 75: 1216–25.
   PubMed Web of Science ®Google Scholar
• Schrier, B. P., Hollander, M. P., van Rhijn, B. W., Kiemeney, L. A., and Witjes, J. A. 2004. Prognosis of muscle-invasive bladder cancer: Difference between primary and progressive tumours and implications for therapy. Eur. Urol. 45: 292–96.
   PubMed Web of Science ®Google Scholar
• Selinski, S. 2014. Urinary bladder cancer risk variants: Recent findings and new challenges of GWAS and confirmatory studies. Arch. Toxicol. 88:1469–75.
   PubMed Web of Science ®Google Scholar
• Sherson, D., Svane, O., and Lynge, E. 1991. Cancer incidence among foundry workers in Denmark. Arch. Environ. Health 46:75–81.
   PubMed Web of Science ®Google Scholar
• van den Bosch, S., and Witjes, A. J. 2011. Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review. Eur. Urol. 60:493–500.
   PubMed Web of Science ®Google Scholar
• van Rhijn, B. W. G., Burger, M., Lotan, Y., Solsona, E., Stief, C. G., Sylvester, R. J., Witjes, J. A., and Zlotta, A. R. 2009. Recurrence and progression of disease in non-muscle-invasive bladder cancer: From epidemiology to treatment strategy. Eur. Urol. 56: 430–42.
   PubMed Web of Science ®Google Scholar
• van Rhijn, B. W. G., Catto, J. W., Goebell, P. J., Knuchel, R., Shariat, S. F., van der Poel, H. G., Sanchez-Carbayo, M., Thalmann, G. N., Schmitz-Drager, B. J., and Kiemeney, L. A. 2014. Molecular markers for urothelial bladder cancer prognosis: Toward implementation in clinical practice. Urol. Oncol. 32:1078–87.
   PubMed Web of Science ®Google Scholar
• Westberg, H., Andersson, L., Bryngelsson, I.-L., Ngo, Y., and Ohlson, C.-G. 2013. Cancer morbidity and quartz exposure in Swedish iron foundries. Int. Arch. Occup. Environ. Health 86: 499–507.
   PubMed Web of Science ®Google Scholar